Peter Duncan

Peter Duncan Email and Phone Number

Vice President, Marketing @ Velsera | Commercial Biotechnology Leader | Life Sciences | Translational Research | Clinical Diagnostics | Precision Medicine @ Velsera
Peter Duncan's Location
San Diego, California, United States, United States
Peter Duncan's Contact Details

Peter Duncan personal email

n/a
About Peter Duncan

Commercial biotechnology leader with over 15 years of demonstrated leadership and success in product management, product marketing, and market development. Specialized in leading teams that surpass high growth targets through a customer-first, solution-centric, evidenced-based approach with an emphasis on key opinion leader development.Skillset includes:#Next Generation Sequencing (NGS) #Marketing Leadership #Market Development #Product Development #Product Management #Clinical Genomics #Life Sciences #Market Research #Team Leadership #Cross-Functional Collaboration #Clinical Diagnostics #IVDs #Precision Healthcare #Oncology #Rare Undiagnosed Disease #Moleculer Diagnostics #Business Case Creation #Laboratory Developed Tests #Marketing Plans & Strategy #Demand Generation #Regulated Markets (FDA)

Peter Duncan's Current Company Details
Velsera

Velsera

View
Vice President, Marketing @ Velsera | Commercial Biotechnology Leader | Life Sciences | Translational Research | Clinical Diagnostics | Precision Medicine
Peter Duncan Work Experience Details
  • Velsera
    Vice President, Marketing
    Velsera Dec 2024 - Present
    Charlestown, Ma, Us
    Velsera’s vision is to be the discovery, evidence generation, and clinical delivery platform for precision medicine. We help doctors and drug hunters make better decisions about providing the right therapy to the right patients at the right time.  We have spent the last 10+ years’ developing industry leading clinical software, knowledge and perspectives on genetic disease - including oncology, rare and hereditary diseases.Velsera was formed in January 2023 through the merger of three leading precision medicine companies – Perian Dx in the clinical diagnostics space, Seven Bridges in the life science analytics domain and UgenTec in the clinical laboratory automation industry.
    View
  • Bio.Logic Advisors Llc
    Founder And Principle
    Bio.Logic Advisors Llc Jan 2024 - Present
    Founder of life sciences consulting firm specializing in:Public Relations • Market Intelligence • Evidence Strategy & Market Access • Go-to-Market Strategy • Marketing & Communications • Commercial Operations • Capital Strategy
    View
  • Mobilion Systems, Inc.
    Head Of Marketing
    Mobilion Systems, Inc. May 2024 - Nov 2024
    Chadds Ford, Pennsylvania, Us
    Led a team of internal and external marketers to enhance brand visibility, customer engagement, and sales of a novel ion mobility platform that improves mass spectrometry performance for drug development, clinical research, food safety, and environmental testing.• Led all aspects of commercial marketing (campaigns, brand, PR, digital, social media, demand generation, collateral generation, conference planning and execution).• Established and managed global marketing budget.• Development of team roles, responsibilities, and goals.• Creation and daily management of 3 comprehensive campaigns aligned to strategic goals.• Development of high value content highlighting customer use cases featuring real world technical and business value propositions for customers and investors.
    View
  • Integrated Dna Technologies
    Global Director, Regional Marketing
    Integrated Dna Technologies Jan 2021 - May 2024
    Coralville, Ia, Us
    Oversaw all global regional marketing campaigns, initiatives and tactics to drive lead generation across APAC, AMR, and EMEA regions.• Led a team of 10 regional marketing managers.• Achieved a perfect manager effectiveness score of 100% in 2022 as voted by direct reports.• Collaborated with senior leadership in product management, product marketing, and sales to generate annual targets, strategies and initiatives.• Significantly exceeded 2023 targets for marketing qualified leads, funnel fill, won funnel, and ecommerce through impactful solution-centric, evidence-based campaigns, promotions, and sales programs.• Enhanced IDT's visibility through the creation of two innovative KOL incubator programs ALIGN and COLLABS featuring the work of industry experts from universities, academic medical institutions, and service providers resulting in 17 co-marketing agreements for 2023.• Executed the company's first account-based marketing program resulting in over $5M incremental sales in the first year deployed.• Significantly empowered direct sales and channel partners by implementing effective internal communication through internal monthly newsletter, participation in regular sales meetings, and routine sales training.• Oversaw more than 3 dozen regional conferences and webinars highlighting real-world results from KOLs to drive demand.• Identified and prioritized several research collaborations aligned with business goals Hamilton, Opentrons, Perkin Elmer, Beckman Coulter).
    View
  • Telesis Bio
    Director, Product Marketing
    Telesis Bio Feb 2020 - Jan 2021
    San Diego, California, Us
    Oversaw product strategy, development, and commercialization of synthetic biology bench top instruments reagents, and services.• Successfully recruited, onboarded, and managed a team of four senior-level product managers.• Led the design and development of two automated synthetic biology platforms BioXp 3250 and BioXp 9600 enabling the generation of DNA fragments, clones, and variant libraries in a single overnight run.• Initiated four Voice of Customer VOC efforts and aligned with senior leadership to provide valuable insights that informed corporate strategy, guided new product development, and shaped product design requirements.• Restructured Product Development Process PDP and introduced post-launch surveillance phase gate review.• Formulated a comprehensive go-to-market strategy and process for the complete product and service portfolio.• Achieved 165% revenue growth year-over-year during the COVID19 pandemic.• Prioritized the development and launch of the world's first SARSCoV2 synthetic genome for research in response to the pandemic resulting in over $1 million in sales within the first three months of availability.
    View
  • Seracare Life Sciences
    Director, Market Development
    Seracare Life Sciences Apr 2018 - Dec 2019
    Milford, Ma, Us
    Commercial leadership role focused on driving early adoption of comprehensive QC solutions (software, reference materials) for small to mid-sized laboratories conducting routine clinical NGS testing.• Formulated a 3-year strategy in collaboration with senior leadership, covering market research, target segment identification, positioning, and pricing.• Conducted VOC survey titled "Trends in Clinical NGS QC Management: A Practitioner Survey" in September 2018.• Developed overview videos, ROI calculators, slide decks, and promotional materials to communicate product benefits.• Collaborated with institutions like Dartmouth Hitchcock Medical Center, Moffitt Cancer Center, and NAVICAN to gather user requirements for upcoming major software releases.• Published thought leader article "Making the Shift from Technological Innovation to Operational Excellence: Delivering on the Promise of Next-Generation Sequencing for Personalized Medicine" in the Journal of Precision Medicine in March 2019.
    View
  • Illumina
    Senior Manager, Product Marketing
    Illumina Oct 2014 - Mar 2018
    San Diego, Ca, Us
    Spearheaded global product marketing efforts for a $120 million portfolio of next-generation sequencing NGS consumables utilized in clinical oncology, rare undiagnosed genetic disease RUGD, and non-invasive prenatal testing NIPT.• Led a comprehensive overhaul of product development, manufacturing, operational, pricing, and positioning, resulting in a 3-year CAGR of 34% and the acquisition of over 30 new customers.• Successfully launched 10 new products generating an additional $20 million in revenue within the first year.• Established a cross-functional order and fulfillment review process improving on-time shipping from 52% to 98%.
    View
  • Illumina
    Manager, Product Marketing
    Illumina Oct 2012 - Oct 2014
    San Diego, Ca, Us
    Launched and promoted the industry's first NGS off-the-shelf portfolio for clinical testing laboratories, featuring TruSight Cancer, TruSight Inherited Disease, TruSight Cardio, and TruSight Autism.• Drove portfolio growth through multimedia KOL testimonials in oncology, cardiology, and rare undiagnosed conditions, emphasizing the relevance of genomics for human health.• Led go-to-market strategy, including KOL adoption for TruSight One, the first "medical exome" solution, resulting in a 50% increase in sales year over year.• Spearheaded the development, planning, and execution of critically acclaimed "Understand Your Genome" symposia, featured in NBC News, Guardian, and Businessweek, involving over a dozen genomics KOLs clinically sequencing their own genomes.
    View
  • Ventana Medical Systems
    Sr. Marketing Manager
    Ventana Medical Systems 2011 - 2012
    Tucson, Arizona, Us
    Oversaw comprehensive management of Ventana's North American advanced staining product portfolio, including IHC, ISH, and instrument platforms, comprising over 300 products with annual revenues exceeding $400 million.• Managed a team of three direct reports.• Successfully launched the Ventana Her2 Dual ISH companion Dx for Herceptin.• Achieved 25% year-over-year growth for advanced staining clinical instrument platforms.
    View
  • Definiens, The Tissue Phenomics Company (Now Astrazeneca)
    Director Marketing & Business Development
    Definiens, The Tissue Phenomics Company (Now Astrazeneca) 2008 - 2011
    Led global strategic and tactical marketing for Definiens' spatial biology software platform, focusing on oncology translational research, clinical diagnostics, and pharmaceutical drug development. Managed three direct reports.• Conceptualized, planned, and executed a comprehensive digital demand generation ecosystem generating over 150 new business opportunities in FY 2010.• Led the development, positioning, and successful launch of Definiens Tissue Studio image analysis software resulting in record software sales.• Developed a spatial biology / digital pathology thought leader roster through "The Definiens Symposium," featuring Nobel Laureate Dr. Gerd Binnig as a keynote speaker for three separate events.• Created the "Digital Pathology Insights" blog, achieving a #1 Google hit ranking for "digital pathology + personalized medicine."
  • Aureon Laboratories
    Vice President, Business Development
    Aureon Laboratories 2006 - 2008
    Developed the pharmaceutical clinical research services program; including all branding, positioning, and promotion. Established and led 6 research collaborations with oncology pharmaceutical drug development partners (Pfizer, Astra Zeneca, Eli Lilly, Biogen) and oncology translational research centers of excellence (UCSF, MD Anderson). Identified, engaged with, and presented to venture capital firms including Rodman and Renshaw.
  • Agencourt Bioscience
    Senior Product Manager
    Agencourt Bioscience 2005 - 2006
    Us
    Product management of Agencourt / Beckman Coulter Genomics SPRI bead kits used in nucleic acid extraction.
    View
  • Quantum Dot Corporation
    Executive Account Manager
    Quantum Dot Corporation 2004 - 2005
    Us
    Market development for a novel gene expression platform.
    View
  • Applied Biosystems
    Genetic Systems Specialist
    Applied Biosystems 2000 - 2004
    Waltham, Ma, Us
    Direct sales of DNA / RNA capital equipment (DNA Sequencers, RT-PCR), reagents and services to pharma, biotech, and academic research centers.
    View

Peter Duncan Skills

Biotechnology Lifesciences Genomics Commercialization Medical Devices Strategy Personalized Medicine Oncology Molecular Biology Life Sciences Product Launch Hardware Diagnostics Genetics Product Management Pharmaceutical Industry Cross Functional Team Leadership Product Development Marketing Strategy Cancer Strategic Planning Product Marketing New Business Development Biochemistry Start Ups R&d Pathology Healthcare Competitive Analysis Bioinformatics Contract Negotiation Negotiation Fda Clinical Research Sales Management Research Business Planning Pcr Data Analysis Diagnostics Clinical Business Strategy Marketing Management Pharmaceuticals Account Management Market Research Customer Relations Imaging Strategy Development Forecasting Licensing

Peter Duncan Education Details

  • University Of Vermont
    University Of Vermont
    Biochemistry

Frequently Asked Questions about Peter Duncan

What company does Peter Duncan work for?

Peter Duncan works for Velsera

What is Peter Duncan's role at the current company?

Peter Duncan's current role is Vice President, Marketing @ Velsera | Commercial Biotechnology Leader | Life Sciences | Translational Research | Clinical Diagnostics | Precision Medicine.

What is Peter Duncan's email address?

Peter Duncan's email address is pd****@****ina.com

What is Peter Duncan's direct phone number?

Peter Duncan's direct phone number is +185825*****

What schools did Peter Duncan attend?

Peter Duncan attended University Of Vermont.

What skills is Peter Duncan known for?

Peter Duncan has skills like Biotechnology, Lifesciences, Genomics, Commercialization, Medical Devices, Strategy, Personalized Medicine, Oncology, Molecular Biology, Life Sciences, Product Launch, Hardware Diagnostics.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.